Pamrevlumab Terminated Phase 2 Trials for Liver Fibrosis Due to Chronic Hepatitis B Infection Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Terminated | Treatment | 2 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT01217632 | A Study of FG-3019 in Subjects With Liver Fibrosis Due to Chronic Hepatitis B Infection |